Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4103/joacp.JOACP_313_20 http://scihub22266oqcxt.onion/10.4103/joacp.JOACP_313_20 33100674!7573985!33100674     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Anaesthesiol+Clin+Pharmacol 2020 ; 36 (Suppl 1): S160-S165 Nephropedia Template TP {{tp|p=33100674|t=2020. Therapeutic status of hydroxychloroquine in COVID-19: A review |pdf=|usr=}}{{33100674}} gab.com Text Therapeutic status of hydroxychloroquine in COVID-19: A review JO: J Anaesthesiol Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33100674 #FOAvip Hydroxychloroquine (HCQ), a 4-aminoquinoline, is used worldwide mainly for its role in management of malaria and rheumatoid arthritis. In the present pandemic of coronavirus disease (COVID)-2019, the drug is being repurposed, based on its in vitro evidence of efficacy against coronavirus. There has been a lot of information, for and against the drug, and this review is an effort to bring forth the evidence and current understanding regarding role of HCQ in COVID-19. Clinical studies, case reports, and in vitro studies have generated conflicting results. There are concerns for use of HCQ because of the variable results and the known adverse effects like QT prolongation and hypoglycemia. In the current scenario, recommendations from Indian Council of Medical Research for use of HCQ in the prophylaxis of COVID-19 are being followed. Twit Text FOAVip Therapeutic status of hydroxychloroquine in COVID-19: A review ????J Anaesthesiol Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33100674 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33100674 #FOAvip English Wikipedia <ref>{{Cite pmid|33100674}}</ref> Therapeutic status of hydroxychloroquine in COVID-19: A review #MMPMID33100674 Kaur K; Kaushal S; Kaushal IG J Anaesthesiol Clin Pharmacol 2020[Aug]; 36 (Suppl 1): S160-S165 PMID33100674show ga Hydroxychloroquine (HCQ), a 4-aminoquinoline, is used worldwide mainly for its role in management of malaria and rheumatoid arthritis. In the present pandemic of coronavirus disease (COVID)-2019, the drug is being repurposed, based on its in vitro evidence of efficacy against coronavirus. There has been a lot of information, for and against the drug, and this review is an effort to bring forth the evidence and current understanding regarding role of HCQ in COVID-19. Clinical studies, case reports, and in vitro studies have generated conflicting results. There are concerns for use of HCQ because of the variable results and the known adverse effects like QT prolongation and hypoglycemia. In the current scenario, recommendations from Indian Council of Medical Research for use of HCQ in the prophylaxis of COVID-19 are being followed. äTherapeutic status of hydroxychloroquine in COVID-19: A review (epmc).pdf DeepDyve Pubget Overpricing